Tilray CEO explains why the stock is beaten down and what’s next
Invezz is an independent platform with the goal of helping users achieve financial freedom. In order to fund our work, we partner with advertisers who compensate us for users that Invezz refers to their services. While our reviews and assessments of each product on the site are independent and unbiased, brands may pay to appear higher up our table rankings or place ads in specific areas of the site. The order in which products and services appear on Invezz does not represent an endorsement from us, and please be aware that there may be other platforms available to you than the products and services that appear on our website. Read more about how we make money >
Apr 20, 2022
Irwin Simon is convinced Europe will legalize cannabis in the next year or so.
Tilray Inc wants to eventually grow its sales in the United States to $1.50 billion.
Tilray Inc (NASDAQ: TLRY) will be cash flow positive in its upcoming fiscal year to start in June, says CEO Irwin Simon. He’s also convinced that Europe will legalize cannabis in the “next year or so”.
Highlights from Simon’s interview on CNBC
TLRY is down more than 55% from its high in mid-November 2021, which Simon attributes to a lack of “institutional” interest in the stock. Speaking with CNBC’s Frank Holland on “Squawk on the Street”, he said:
Are you looking for fast-news, hot-tips and market analysis?
Sign-up for the Invezz newsletter, today.
Institutions are not owning cannabis stocks right now. We have over 400 million shares outstanding. Majority of our shareholders today are retail shareholders that are in and out. So, I think the SAFE Banking Act passing is important.
He, however, sees big success for Tilray in the future as the world continues to legalize the medical and recreational use of cannabis that will eventually bring institutional investors to the stock.
Tilray wants to massively grow its U.S. revenue
Earlier in April, Tilray reported just over $150 million in revenue for its fiscal third quarter – a number that CEO Simon expects to eventually grow by 10 folds. He added:
We have a plan in place and ultimately, we see legalisation happening within the U.S. We’ll look to either buy, merge, or something and have billion and a half dollars of sales within the United States.
The cannabis-lifestyle and consumer packaged goods company already owns Breckenridge Distillery and SweetWater Brewing Company in the U.S. Tilray also announced a strategic partnership with Hexo Corp last month.
68% of retail CFD accounts lose money
Health & pharmaceuticals
Stocks & Shares